United States Restriction Endonucleases Market Report 2016

Publisher Name :
Date: 05-Oct-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Restriction Endonucleases

Revenue, means the sales value of Restriction Endonucleases

This report studies sales (consumption) of Restriction Endonucleases in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Thermo Fisher Scientific, Inc. (U.S.)

- Merck KGaA (Germany)

- New England Biolabs, Inc. (U.S.)

- Promega (U.S.)

- Illumina, Inc. (U.S.)

- Agilent Technologies, Inc. (U.S.)

- F. Hoffmann-la Roche Ltd. (Switzerland)

- Takara Bio Inc. (Japan)

- QIAGEN N.V. (The Netherlands)

- Becton, Dickinson and Company (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Restriction Endonucleases in each application, can be divided into

- PCR

- Sequencing

- Cloning

United States Restriction Endonucleases Market Report 2016

Table of Contents
United States Restriction Endonucleases Market Report 2016
1 Restriction Endonucleases Overview
1.1 Product Overview and Scope of Restriction Endonucleases
1.2 Classification of Restriction Endonucleases
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Restriction Endonucleases
1.3.1 PCR
1.3.2 Sequencing
1.3.3 Cloning
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Restriction Endonucleases (2011-2021)
1.4.1 United States Restriction Endonucleases Sales and Growth Rate (2011-2021)
1.4.2 United States Restriction Endonucleases Revenue and Growth Rate (2011-2021)
2 United States Restriction Endonucleases Competition by Manufacturers
2.1 United States Restriction Endonucleases Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Restriction Endonucleases Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Restriction Endonucleases Average Price by Manufactures (2015 and 2016)
2.4 Restriction Endonucleases Market Competitive Situation and Trends
2.4.1 Restriction Endonucleases Market Concentration Rate
2.4.2 Restriction Endonucleases Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Restriction Endonucleases Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Restriction Endonucleases Sales and Market Share by Type (2011-2016)
3.2 United States Restriction Endonucleases Revenue and Market Share by Type (2011-2016)
3.3 United States Restriction Endonucleases Price by Type (2011-2016)
3.4 United States Restriction Endonucleases Sales Growth Rate by Type (2011-2016)
4 United States Restriction Endonucleases Sales (Volume) by Application (2011-2016)
4.1 United States Restriction Endonucleases Sales and Market Share by Application (2011-2016)
4.2 United States Restriction Endonucleases Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Restriction Endonucleases Manufacturers Profiles/Analysis
5.1 Thermo Fisher Scientific, Inc. (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Restriction Endonucleases Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Thermo Fisher Scientific, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Merck KGaA (Germany)
5.2.2 Restriction Endonucleases Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Merck KGaA (Germany) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 New England Biolabs, Inc. (U.S.)
5.3.2 Restriction Endonucleases Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 New England Biolabs, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Promega (U.S.)
5.4.2 Restriction Endonucleases Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Promega (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Illumina, Inc. (U.S.)
5.5.2 Restriction Endonucleases Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Illumina, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Agilent Technologies, Inc. (U.S.)
5.6.2 Restriction Endonucleases Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Agilent Technologies, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 F. Hoffmann-la Roche Ltd. (Switzerland)
5.7.2 Restriction Endonucleases Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 F. Hoffmann-la Roche Ltd. (Switzerland) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Takara Bio Inc. (Japan)
5.8.2 Restriction Endonucleases Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Takara Bio Inc. (Japan) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 QIAGEN N.V. (The Netherlands)
5.9.2 Restriction Endonucleases Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 QIAGEN N.V. (The Netherlands) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Becton, Dickinson and Company (U.S.)
5.10.2 Restriction Endonucleases Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Becton, Dickinson and Company (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Restriction Endonucleases Manufacturing Cost Analysis
6.1 Restriction Endonucleases Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Restriction Endonucleases
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Restriction Endonucleases Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Restriction Endonucleases Market Forecast (2016-2021)
10.1 United States Restriction Endonucleases Sales, Revenue Forecast (2016-2021)
10.2 United States Restriction Endonucleases Sales Forecast by Type (2016-2021)
10.3 United States Restriction Endonucleases Sales Forecast by Application (2016-2021)
10.4 Restriction Endonucleases Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Restriction Endonucleases
Table Classification of Restriction Endonucleases
Figure United States Sales Market Share of Restriction Endonucleases by Type in 2015
Table Application of Restriction Endonucleases
Figure United States Sales Market Share of Restriction Endonucleases by Application in 2015
Figure PCR Examples
Figure Sequencing Examples
Figure Cloning Examples
Figure United States Restriction Endonucleases Sales and Growth Rate (2011-2021)
Figure United States Restriction Endonucleases Revenue and Growth Rate (2011-2021)
Table United States Restriction Endonucleases Sales of Key Manufacturers (2015 and 2016)
Table United States Restriction Endonucleases Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Restriction Endonucleases Sales Share by Manufacturers
Figure 2016 Restriction Endonucleases Sales Share by Manufacturers
Table United States Restriction Endonucleases Revenue by Manufacturers (2015 and 2016)
Table United States Restriction Endonucleases Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Restriction Endonucleases Revenue Share by Manufacturers
Table 2016 United States Restriction Endonucleases Revenue Share by Manufacturers
Table United States Market Restriction Endonucleases Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Restriction Endonucleases Average Price of Key Manufacturers in 2015
Figure Restriction Endonucleases Market Share of Top 3 Manufacturers
Figure Restriction Endonucleases Market Share of Top 5 Manufacturers
Table United States Restriction Endonucleases Sales by Type (2011-2016)
Table United States Restriction Endonucleases Sales Share by Type (2011-2016)
Figure United States Restriction Endonucleases Sales Market Share by Type in 2015
Table United States Restriction Endonucleases Revenue and Market Share by Type (2011-2016)
Table United States Restriction Endonucleases Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Restriction Endonucleases by Type (2011-2016)
Table United States Restriction Endonucleases Price by Type (2011-2016)
Figure United States Restriction Endonucleases Sales Growth Rate by Type (2011-2016)
Table United States Restriction Endonucleases Sales by Application (2011-2016)
Table United States Restriction Endonucleases Sales Market Share by Application (2011-2016)
Figure United States Restriction Endonucleases Sales Market Share by Application in 2015
Table United States Restriction Endonucleases Sales Growth Rate by Application (2011-2016)
Figure United States Restriction Endonucleases Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific, Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific, Inc. (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA (Germany) Restriction Endonucleases Sales Market Share (2011-2016)
Table New England Biolabs, Inc. (U.S.) Basic Information List
Table New England Biolabs, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs, Inc. (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Promega (U.S.) Basic Information List
Table Promega (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promega (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Basic Information List
Table Agilent Technologies, Inc. (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-la Roche Ltd. (Switzerland) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Restriction Endonucleases Sales Market Share (2011-2016)
Table Takara Bio Inc. (Japan) Basic Information List
Table Takara Bio Inc. (Japan) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takara Bio Inc. (Japan) Restriction Endonucleases Sales Market Share (2011-2016)
Table QIAGEN N.V. (The Netherlands) Basic Information List
Table QIAGEN N.V. (The Netherlands) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table QIAGEN N.V. (The Netherlands) Restriction Endonucleases Sales Market Share (2011-2016)
Table Becton, Dickinson and Company (U.S.) Basic Information List
Table Becton, Dickinson and Company (U.S.) Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton, Dickinson and Company (U.S.) Restriction Endonucleases Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Restriction Endonucleases
Figure Manufacturing Process Analysis of Restriction Endonucleases
Figure Restriction Endonucleases Industrial Chain Analysis
Table Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2015
Table Major Buyers of Restriction Endonucleases
Table Distributors/Traders List
Figure United States Restriction Endonucleases Production and Growth Rate Forecast (2016-2021)
Figure United States Restriction Endonucleases Revenue and Growth Rate Forecast (2016-2021)
Table United States Restriction Endonucleases Production Forecast by Type (2016-2021)
Table United States Restriction Endonucleases Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • 2017-2022 United States Herbal Medicine Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed." The Herbal Medicine market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include - Tsumura - Schwabe - Madaus - Weleda - Blackmores - Arkopharma - SIDO MUNCUL - Arizo......
  • 2017-2022 United States Bovine Lactoferrin Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed." The Bovine Lactoferrin market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include - Fonterra Group - Bega Cheese - FrieslandCampina (DMV) - Milei Gmbh - Glanbia Nutritionals - We......
  • 2017-2022 Philippines Herbal Medicine Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed." The Herbal Medicine market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Philippines market, the top players include - Tsumura - Schwabe - Madaus - Weleda - Blackmores - Arkopharma - SIDO MUNCUL - Arizona N......
  • 2017-2022 Philippines Bovine Lactoferrin Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed." The Bovine Lactoferrin market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Philippines market, the top players include - Fonterra Group - Bega Cheese - FrieslandCampina (DMV) - Milei Gmbh - Glanbia Nutritionals - Westla......
  • 2017-2022 Malaysia Herbal Medicine Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed." The Herbal Medicine market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Malaysia market, the top players include - Tsumura - Schwabe - Madaus - Weleda - Blackmores - Arkopharma - SIDO MUNCUL - Arizona Natural......
  • 2017-2022 Malaysia Bovine Lactoferrin Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed." The Bovine Lactoferrin market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Malaysia market, the top players include - Fonterra Group - Bega Cheese - FrieslandCampina (DMV) - Milei Gmbh - Glanbia Nutritionals - Westland Mil......
  • 2017-2022 Japan Herbal Medicine Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed." The Herbal Medicine market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include - Tsumura - Schwabe - Madaus - Weleda - Blackmores - Arkopharma - SIDO MUNCUL - Arizona Natural......
  • 2017-2022 Japan Bovine Lactoferrin Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed." The Bovine Lactoferrin market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include - Fonterra Group - Bega Cheese - FrieslandCampina (DMV) - Milei Gmbh - Glanbia Nutritionals - Westland Milk......
  • 2017-2022 India Herbal Medicine Market Report (Status and Outlook)
    Published: 22-May-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed." The Herbal Medicine market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include - Tsumura - Schwabe - Madaus - Weleda - Blackmores - Arkopharma - SIDO MUNCUL - Arizona Natural......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs